GO:0042662 negative regulation of mesodermal cell fate specification: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042662 describes any process that stops, prevents, or reduces the frequency, rate or extent of mesoderm cell fate specification, a critical checkpoint in early embryonic development.
• Polycomb group proteins are central negative regulators of mesodermal cell fate specification in embryonic stem cells, acting through both activation and repression mechanisms.
• Wnt signaling is required for mesoderm induction, and its inhibition blocks the expression of mesodermal markers such as MyoD in Xenopus embryos.
• Retinoic acid signaling influences pronephric cell fate specification, which derives from intermediate mesoderm, demonstrating the interplay between negative regulation and lineage-specific outcomes.
• Dysregulation of mesodermal cell fate specification is linked to developmental disorders and cancers, making this process a target for disease modeling.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise interrogation of genes controlling negative regulation of mesodermal cell fate specification.
Description
Mesodermal cell fate specification is a fundamental step in embryonic development, giving rise to muscles, bones, blood, and other mesodermal derivatives. The Gene Ontology term GO:0042662, negative regulation of mesodermal cell fate specification, captures the biological processes that restrict or prevent cells from adopting a mesodermal identity. This term is essential for understanding how embryos balance lineage commitment and how perturbations can lead to disease. Research has shown that Polycomb group proteins act as key negative regulators of mesoderm specification in embryonic stem cells, using both activation and repression mechanisms to control cell fate decisions. Similarly, Wnt signaling is required for mesoderm induction, and its inhibition by dominant-negative Wnt blocks the expression of MyoD, a master myogenic regulator, in Xenopus embryos. These findings highlight the importance of negative regulatory mechanisms in shaping mesodermal lineages. Understanding GO:0042662 is therefore critical for developmental biologists, stem cell researchers, and cancer biologists, as misregulation of mesodermal fate specification can contribute to developmental abnormalities and oncogenesis. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview of the mechanisms, genes, and research methods associated with negative regulation of mesodermal cell fate specification.
negative regulation of mesodermal cell fate specification At A Glance
| GO ID | GO:0042662 |
|---|---|
| GO term | negative regulation of mesodermal cell fate specification |
| Ontology | biological_process |
| Synonym | down regulation of mesodermal cell fate specification, down-regulation of mesodermal cell fate specification, downregulation of mesodermal cell fate specification, inhibition of mesodermal cell fate specification, suppression of mesodermal cell fate |
| Major function | Inhibits or reduces the specification of mesodermal cell fate during embryonic development |
| Related process | Mesodermal cell fate specification (GO:0001707) |
| Regulatory context | Polycomb group proteins, Wnt signaling, retinoic acid signaling |
| Disease relevance | Developmental disorders, cancer, stem cell dysregulation |
What Is GO:0042662?
GO:0042662, negative regulation of mesodermal cell fate specification, is defined as any process that stops, prevents, or reduces the frequency, rate or extent of mesoderm cell fate specification. In other words, it encompasses molecular and cellular events that inhibit the commitment of cells to a mesodermal lineage, ensuring proper spatiotemporal control of germ layer formation during development.
Why Is negative regulation of mesodermal cell fate specification Important in Cell Biology?
Negative regulation of mesodermal cell fate specification is crucial for proper embryonic development because it prevents excessive or ectopic mesoderm formation, which can disrupt tissue patterning and organogenesis. This process also plays a role in stem cell differentiation and cancer, where aberrant mesodermal specification can contribute to tumor heterogeneity and metastasis. Understanding GO:0042662 provides insights into fundamental developmental mechanisms and offers potential therapeutic targets for diseases linked to mesodermal dysregulation.
• Ensures correct germ layer formation by restricting mesodermal fate to appropriate cells.
• Prevents ectopic mesoderm induction that could lead to developmental malformations.
• Regulates muscle, bone, and blood lineage commitment through inhibition of mesodermal specification.
• Involved in stem cell pluripotency and differentiation decisions.
• Dysregulation is associated with cancers such as sarcoma and teratoma.
• Provides a model for studying Polycomb-mediated gene repression.
• Interacts with Wnt and retinoic acid signaling pathways.
• Relevant for regenerative medicine and directed differentiation protocols.
• Helps explain clonal variation in induced pluripotent stem cell differentiation.
• Offers targets for CRISPR-based functional genomics screens.
What Happens During negative regulation of mesodermal cell fate specification?
Initiation of negative regulation
In simple terms: The process begins when specific signals tell a cell not to become mesoderm.
Negative regulation of mesodermal cell fate specification is initiated by extracellular and intracellular cues that counteract mesoderm-inducing signals. For example, inhibition of Wnt signaling by dominant-negative Wnt blocks the induction of MyoD, a key mesodermal marker, in Xenopus embryos. This suggests that Wnt activity is required for mesoderm specification, and its negative regulation prevents inappropriate mesodermal commitment.
Polycomb-mediated repression
In simple terms: Polycomb proteins act like brakes that keep mesoderm genes turned off.
Polycomb group proteins regulate mesoderm cell fate specification in embryonic stem cells through both activation and repression mechanisms. They deposit repressive histone marks at mesodermal gene loci, thereby preventing their expression and blocking mesodermal differentiation. This epigenetic silencing is a key mechanism of negative regulation.
Integration with retinoic acid signaling
In simple terms: Retinoic acid helps fine-tune which cells become mesoderm-derived tissues.
Retinoic acid signaling is required for specification of pronephric cell fate, which arises from intermediate mesoderm. Negative regulation of mesodermal cell fate specification may intersect with retinoic acid pathways to ensure proper patterning of mesodermal derivatives, although direct evidence for negative regulation by retinoic acid in this context is still emerging.
Outcome: blocked mesodermal differentiation
In simple terms: The end result is that cells do not become mesoderm, preserving other fates.
When negative regulation is active, cells fail to express mesodermal markers such as MyoD and do not undergo mesodermal differentiation. This allows them to adopt alternative fates, such as ectodermal or endodermal lineages, or remain in a pluripotent state.
Key Genes Involved in GO:0042662 negative regulation of mesodermal cell fate specification
The following genes and proteins have been implicated in the negative regulation of mesodermal cell fate specification, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Wnt | Induces mesoderm; its inhibition blocks MyoD expression | Dominant-negative Wnt blocks mesoderm induction in Xenopus |
| MyoD | Master myogenic regulator; marker of mesodermal commitment | Its expression is blocked by negative regulation |
| Polycomb group proteins | Repress mesodermal genes via histone modification | Regulate mesoderm specification in ESCs |
| Retinoic acid receptor | Mediates retinoic acid signaling for pronephric fate | Required for pronephric cell fate specification |
| VEGF | Regulates endothelial differentiation and arterial specification | Linked to mesodermal derivatives |
| Notch | Signaling in endothelial differentiation | Interacts with VEGF in mesodermal lineages |
| CARMA | Long non-coding RNA regulating cardiomyocyte differentiation | Conserved lncRNA in mesodermal derivatives |
| Exogenous plant miRNAs | Detected in chicken; potential regulators | Expression patterns in chickens |
| Induced pluripotent stem cells | Model for germ cell fate induction | Clonal variation affects differentiation |
| Myogenesis regulators | Initiate myogenesis from mesoderm | Reviewed in |
| Endothelial cell differentiation genes | Regulate arterial specification | Reviewed in |
| Pronephric cell fate genes | Specify pronephric fate from intermediate mesoderm | Studied in Xenopus |
| Cardiomyocyte differentiation genes | Regulate heart development | CARMA lncRNA involved |
| Germ cell fate genes | Induce germ cell fate from iPSCs | Clonal variation studied |
| Chicken miRNA targets | Plant miRNA expression in chickens | Potential cross-kingdom regulation |
| Mesodermal cell fate specification genes | Core regulators of mesoderm commitment | Subject to negative regulation |
How Is negative regulation of mesodermal cell fate specification Regulated?
Negative regulation of mesodermal cell fate specification is controlled by a network of signaling pathways and epigenetic modifiers. Polycomb group proteins repress mesodermal genes through histone modifications, while Wnt signaling provides inductive cues that are counteracted by negative regulators. Retinoic acid signaling also influences mesodermal derivatives, as shown by its requirement for pronephric cell fate specification. Additionally, long non-coding RNAs such as CARMA regulate cardiomyocyte differentiation, a mesodermal lineage. These regulatory layers ensure precise spatiotemporal control of mesoderm formation.
negative regulation of mesodermal cell fate specification and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Polycomb group proteins | Cancer, developmental disorders | Knockout ESCs, cancer cell lines |
| Wnt | Developmental defects, cancer | Dominant-negative Wnt in Xenopus |
| MyoD | Muscle disorders, rhabdomyosarcoma | Overexpression in myoblasts |
| Retinoic acid receptor | Pronephric malformations | Retinoic acid treatment in Xenopus |
| CARMA | Cardiovascular disease | Knockout in cardiomyocytes |
Cancer and aberrant mesodermal differentiation
Dysregulation of mesodermal cell fate specification can contribute to tumorigenesis, particularly in sarcomas and teratomas where mesodermal lineages are improperly specified. Polycomb group proteins, which negatively regulate mesoderm specification, are frequently mutated or misexpressed in cancers, leading to altered differentiation states.
Developmental disorders
Failure to properly negatively regulate mesodermal cell fate specification can cause developmental malformations, including skeletal and muscular defects. For example, ectopic MyoD expression due to loss of negative regulation can lead to abnormal muscle formation.
Stem cell dysregulation and regenerative medicine
Clonal variation in human induced pluripotent stem cells affects their ability to differentiate into germ cell fates, which are mesodermal derivatives. Understanding negative regulation of mesodermal specification is essential for optimizing directed differentiation protocols for regenerative therapies.
From negative regulation of mesodermal cell fate specification-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate mesodermal specification? | CRISPR knockout in ESCs |
| Does a point mutation in gene Y affect mesodermal fate? | CRISPR point mutation knock-in |
| Can overexpression of gene Z block mesoderm induction? | CRISPR overexpression |
| Where is protein X localized during negative regulation? | Tagged knock-in |
| What is the transcriptomic impact of gene X knockout? | RNA-seq after CRISPR KO |
| Does gene X interact with Polycomb complex? | Co-IP in knockout ESCs |
How to Study the negative regulation of mesodermal cell fate specification Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Knockout vs wild-type ESCs |
| ChIP-seq | Histone modifications and transcription factor binding | Polycomb repression at mesodermal genes |
| Luciferase reporter | Promoter activity | MyoD promoter inhibition by dominant-negative Wnt |
| Immunofluorescence | Protein localization and expression | Mesodermal markers in embryos |
| CRISPR screen | Functional gene identification | Negative regulators of mesoderm specification |
| Single-cell RNA-seq | Cell fate heterogeneity | Clonal variation in iPSCs |
| Co-immunoprecipitation | Protein-protein interactions | Polycomb complex components |
Transcriptomic profiling
RNA-seq can be used to measure changes in mesodermal gene expression upon perturbation of negative regulators. For example, knockout of Polycomb genes in ESCs leads to altered mesodermal marker expression.
Epigenomic analysis
ChIP-seq for repressive histone marks such as H3K27me3 can reveal Polycomb-mediated repression at mesodermal loci.
Reporter assays
Luciferase reporters driven by mesodermal promoters (e.g., MyoD) can assess negative regulation in response to Wnt inhibition.
Imaging and lineage tracing
Fluorescent reporters and live imaging in Xenopus or mouse embryos can visualize mesodermal cell fate specification and its negative regulation.
How CRISPR Can Be Used to Study GO:0042662 negative regulation of mesodermal cell fate specification
Knockout
CRISPR knockout of candidate negative regulators such as Polycomb genes can be used to test whether they are required to prevent mesodermal specification. Loss of function may lead to ectopic mesodermal marker expression.
Point Mutation
Point mutations can be introduced to dissect specific domains or residues of negative regulators, such as Wnt signaling components, to determine their role in blocking mesoderm induction.
Knock-in
Knock-in of fluorescent tags or epitope tags allows visualization and biochemical analysis of negative regulators in their endogenous context, e.g., tagging Polycomb proteins.
Overexpression
Overexpression of negative regulators, such as dominant-negative Wnt, can block mesodermal differentiation and MyoD expression, providing gain-of-function evidence.
How EDITGENE Supports negative regulation of mesodermal cell fate specification Research
Researchers studying negative regulation of mesodermal cell fate specification-related genes often need to determine whether a candidate gene is causally involved in this process. EDITGENE provides comprehensive CRISPR-based services to enable precise genetic perturbations in relevant cell models.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of mesodermal cell fate specification research.
Frequently Asked Questions About negative regulation of mesodermal cell fate specification
What is GO:0042662?
GO:0042662 is the Gene Ontology term for negative regulation of mesodermal cell fate specification, describing processes that inhibit or reduce the specification of mesodermal cell fate.
What genes are involved in negative regulation of mesodermal cell fate specification?
Key genes include Polycomb group proteins, Wnt, MyoD, and retinoic acid receptors.
How does Polycomb regulate mesodermal cell fate?
Polycomb proteins repress mesodermal genes through histone modifications, acting as negative regulators.
What is the role of Wnt signaling in mesoderm specification?
Wnt signaling induces mesoderm, and its inhibition blocks MyoD expression, demonstrating negative regulation.
Why is negative regulation of mesodermal cell fate specification important?
It prevents ectopic mesoderm formation and ensures proper germ layer patterning during development.
What diseases are associated with dysregulation of this process?
Dysregulation is linked to cancers such as sarcoma and developmental disorders.
How can CRISPR be used to study this process?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional interrogation of candidate genes.
What methods are used to study negative regulation of mesodermal cell fate specification?
RNA-seq, ChIP-seq, reporter assays, and imaging are commonly used.
Does retinoic acid signaling play a role?
Retinoic acid signaling is required for pronephric cell fate specification, a mesodermal derivative.
What cell models are available for research?
ESCs, iPSCs, Xenopus embryos, and cardiomyocytes are used to study this process.
Conclusion
Negative regulation of mesodermal cell fate specification (GO:0042662) is a vital developmental process that ensures proper germ layer formation by inhibiting inappropriate mesodermal commitment. Key regulators such as Polycomb group proteins and Wnt signaling components have been identified through studies in embryonic stem cells and Xenopus embryos. Dysregulation of this process is associated with cancer and developmental disorders, highlighting its clinical relevance. Advances in CRISPR-based gene editing and functional genomics provide powerful tools to further dissect the mechanisms and identify novel therapeutic targets.
References
- 1. Hirashima M. 2009. Regulation of endothelial cell differentiation and arterial specification by VEGF and Notch signaling.. Anat Sci Int 84(3):95-101 PMID: 19259767
- 2. Cartry J et al.. 2006. Retinoic acid signalling is required for specification of pronephric cell fate.. Dev Biol 299(1):35-51 PMID: 16979153
- 3. Cossu G et al.. 1996. How is myogenesis initiated in the embryo?. Trends Genet 12(6):218-23 PMID: 8928226
- 4. Li H et al.. 2023. The Expression Patterns of Exogenous Plant miRNAs in Chickens.. Genes (Basel) 14(3) PMID: 36981030
- 5. Kay M et al.. 2022. The conserved long non-coding RNA CARMA regulates cardiomyocyte differentiation.. Cardiovasc Res 118(10):2339-2353 PMID: 34459880
- 6. Morey L et al.. 2015. Polycomb Regulates Mesoderm Cell Fate-Specification in Embryonic Stem Cells through Activation and Repression Mechanisms.. Cell Stem Cell 17(3):300-15 PMID: 26340528
- 7. Hoppler S et al.. 1996. Expression of a dominant-negative Wnt blocks induction of MyoD in Xenopus embryos.. Genes Dev 10(21):2805-17 PMID: 8946920
- 8. Yokobayashi S et al.. 2017. Clonal variation of human induced pluripotent stem cells for induction into the germ cell fate.. Biol Reprod 96(6):1154-1166 PMID: 28453617
